Literature DB >> 23238745

uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors.

Nunzia Montuori1, Vincenzo Cosimato, Loredana Rinaldi, Vincenza Elena Anna Rea, Daniela Alfano, Pia Ragno.   

Abstract

The expression of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR) can be regulated by several hormones, cytokines, and tumour promoters. uPAR is a glycosyl-phosphatidyl inositol (GPI)-linked cell-surface protein; however, it is capable to transduce signals inside the cell by interacting with other cell-surface proteins, such as integrins and G-protein coupled (GPC) receptors. We previously reported that uPAR cell-surface expression can be positively regulated by its ligand, uPA, independently of its proteolytic activity. We now demonstrate that uPAR overexpression induces or increases uPA secretion both in uPAR-negative and in uPAR-expressing cells. Accordingly, uPAR depletion impairs uPA expression in cells which constitutively express both uPA and its receptor. uPAR exerts its regulatory effect through the activation of the ERK mitogen-activated protein kinases (MAPKs), whereas the p-38 MAPK is not involved. Overexpression of truncated forms of uPAR, lacking the N-terminal domain (DI) and not able to interact with membrane co-receptors, failed to increase uPA expression. Inhibition of uPAR-integrin interaction by the specific P-25 peptide, as well as Gi-protein inhibition by cholera pertussin toxin or depletion of the GPC receptors for fMLF (fMLF-Rs) also impaired uPAR capability to regulate uPA expression. These findings demonstrate that uPAR, whose expression is regulated by uPA, can, in turn, regulate uPA expression through a mechanism involving its functional interaction with integrins and fMLF-Rs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23238745     DOI: 10.1160/TH12-08-0546

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  14 in total

1.  Effect of urokinase-type plasminogen activator system in gastric cancer with peritoneal metastasis.

Authors:  Youcheng Ding; Hui Zhang; Aiguo Lu; Zhuqing Zhou; Mingan Zhong; Dongwei Shen; Xujing Wang; Zhenggang Zhu
Journal:  Oncol Lett       Date:  2016-04-26       Impact factor: 2.967

2.  Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells.

Authors:  Daniela Alfano; Anna Gorrasi; Anna Li Santi; Patrizia Ricci; Nunzia Montuori; Carmine Selleri; Pia Ragno
Journal:  J Cell Mol Med       Date:  2015-06-16       Impact factor: 5.310

3.  Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling.

Authors:  J Hu; K A Muller; F B Furnari; W K Cavenee; S R VandenBerg; S L Gonias
Journal:  Oncogene       Date:  2014-10-27       Impact factor: 9.867

Review 4.  uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies.

Authors:  Michael J Duffy; Patricia M McGowan; Nadia Harbeck; Christoph Thomssen; Manfred Schmitt
Journal:  Breast Cancer Res       Date:  2014-08-22       Impact factor: 6.466

5.  Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer.

Authors:  Nunzia Montuori; Ada Pesapane; Francesca W Rossi; Valentina Giudice; Amato De Paulis; Carmine Selleri; Pia Ragno
Journal:  Transl Med UniSa       Date:  2016-11-01

6.  Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors.

Authors:  Concetta Di Mauro; Ada Pesapane; Luigi Formisano; Roberta Rosa; Valentina D'Amato; Paola Ciciola; Alberto Servetto; Roberta Marciano; Roberta Clara Orsini; Francesca Monteleone; Nicola Zambrano; Gabriella Fontanini; Adele Servadio; Giuseppe Pignataro; Lucia Grumetto; Antonio Lavecchia; Dario Bruzzese; Antonino Iaccarino; Giancarlo Troncone; Bianca Maria Veneziani; Nunzia Montuori; Sabino De Placido; Roberto Bianco
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

Review 7.  Fibrinolytic and coagulative activities of Yersinia pestis.

Authors:  Timo K Korhonen; Johanna Haiko; Liisa Laakkonen; Hanna M Järvinen; Benita Westerlund-Wikström
Journal:  Front Cell Infect Microbiol       Date:  2013-07-26       Impact factor: 5.293

8.  The urokinase receptor takes control of cell migration by recruiting integrins and FPR1 on the cell surface.

Authors:  Anna Gorrasi; Anna Li Santi; Giuseppina Amodio; Daniela Alfano; Paolo Remondelli; Nunzia Montuori; Pia Ragno
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

9.  Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine.

Authors:  Xuanbin Wang; Ning Wang; Hongliang Li; Ming Liu; Fengjun Cao; Xianjun Yu; Jingxuan Zhang; Yan Tan; Longchao Xiang; Yibin Feng
Journal:  Int J Mol Sci       Date:  2016-04-16       Impact factor: 5.923

Review 10.  Plasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision Medicine.

Authors:  Adel Gouri; Aoulia Dekaken; Khalid El Bairi; Arifa Aissaoui; Nihad Laabed; Mohamed Chefrour; Joseph Ciccolini; Gérard Milano; Sadek Benharkat
Journal:  Biomark Insights       Date:  2016-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.